Abstract
Objective
To examine the expressions of MDM2, P53 and P27 proteins in chronic esophagitis, para-cancer mucosa and esophageal carcinoma.
Methods
Immunohistochemistry was used to detect the expressions of MDM2, P53 and P27 proteins in forty-seven patients suffering from chronic esophagitis and eighty-five cases of esophageal carcinoma and corresponding para-cancer mucosa. Flow cytometry ( (FCM) was applied to detect the quantities of these proteins expressed in fresh tissues of 48 cases of esophageal cancer and their para-cancer tissues and 24 cases of relative normal mucosa at the surface of cutting edge.
Results
Immunohistochemistry results showed that the expressions of the three studied proteins were very similar in the epithelia of chronic esophagitis and para-cancer mucosa (P>0.05). both the qualitative and quantitative studies displayed that the P53 protein had no expression and its accumulations would appear only in the early stages of esophagus canceration while the MDM2 and P27 proteins had different degrees of expressions in cases of normal esophageal muscosa. MDM2 protein markedly increased in the advanced stages of esophageal canceration. A quantitative study showed that the expression of P27 protein had a linearity of decreasing tendency (F=9.132, P=0.002) in the course of esophageal canceration.
Conclusion
Chronic esophagitis may be a precancerous lesion. Owing to the changes of the P53 and P27 proteins, we can also conclude that these occur in the early stages of esophagus oncogenesis, however the changes of MDM2 expression may occur in the advanced stage of esophageal canceration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wang LD, Zhou Q, Yang CS. Esophageal and gastric cardia epithelial cell proliferation in northen Chinese subjects living in high-incidence area[J]. J Cell Biochem Suppls 1997; 28/29: 159–165.
SU M, LIU M, TIAN DP, et al. Epidemiological Investigating of the Morbidity Rate of Malignant Tumors and Their Diet Habitats among Residents of Nanao Island in South China Sea[J]. J Environ Occup Med 2005; 22: 312–316.
LI CX, WU MY. A comparative study of oncogene protein expressions in the epithelia of chronic esophagitis and para-cancer[J]. Carcinogen Teratogen Mutagen (Chin) 2004; 16: 332–336.
MY Wu, XY Wu, QS Li, et al. Expression of Egr-1 gene and its correlation with the oncogene proteins in non-irradiated and irradiated esophageal squamous cell carcinoma[J]. Dis Esophagus 2006; 19: 267–272.
Ohbu M, Kobayashi N, Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1)[J]. Histopathol 2001; 39: 589–596.
Chen H, Wang LD, Guo M, et al. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China[J]. World J Gastroenterol 2003; 9: 16–21.
Mandar AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus[J]. Mutat Res 2000; 462: 335–342.
Chang-claude JC, Wahrendorf J, Liang QS, et al. An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Huixian[J]. China Cancer Res (Chin) 1990; 50: 2268–2274.
Saito H, Tsujitani S, Oka S, et al. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation[J]. Ann Surg Oncol 2002; 9: 450–456.
Hagiwara N, Tajiri T, Miyashita M, et al. Biological Behavior of Mucoepidermoid carcinoma of the esophagus[J]. J Nippon Med Sch 2003; 70: 401–407.
Rosa AR, Schirmer CC, Gurski RR, et al. Prognostic value of p53 protein expression and vascular endothelial growth factor: expression in resected squamous cell carcinoma of the esophagus[J]. Dis Esophagus 2003; 16: 112–118.
Ito T, Kaneko K, Makino R, et al. Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy[J]. World J Gastroenterol 2001; 36: 303–311.
Xiangminga C, Hokitaa S, Natsugoea S, et al. Cooccurrence of Reduced Expression of α-Catenin and Overexpression of p53 is a Predictor of Lymph Node Metastasis in Early Gastric Cancer[J]. Oncology 1999; 57: 131–137.
Kagawa Y, Yoshida K, Hirai T, et al. Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas[J]. Dis Esophagus 2000; 13: 179–184.
Ohashi Y, Sasano H, Yamaki H, et al. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma[J]. Anticancer Res 1999; 19: 1843–1848.
Chetty R. p27 Protein and cancers of the gastrointestinal tract and liver: an overview[J]. J Clin Gastroenterol 2003; 37: 23–27.
Shibata H, Matsubara O, Wakiyama H, et al. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus[J]. Pathol Res Pract 2001; 197: 157–164.
Shamma A, Doki Y, Tsujinaka T, et al. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma[J]. Oncology 2000; 58: 152–158.
Chen S H, Hong DX, Ye X, et al. Clinicopathological study of p27 and p53 expression in esophageal cancer[J]. Chin J Modern Med (Chin) 2002; 12: 7–9.
Arora S, Mathew R, Mathur M, et al. Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status[J]. Pathol Oncol Res 2001; 7: 203–208.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Cx., Wu, My. & Kuang, Lp. Qualitative and quantitative studies of polygene proteins expression in esophageal precancerous lesions and esophageal carcinoma. Chin. J. Cancer Res. 19, 100–107 (2007). https://doi.org/10.1007/s11670-007-0100-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-007-0100-y